Q2 2026 13F · SEC CIK 1596452

Sivik Global Healthcare LLC

Hedge fundFiled 2026-07-20 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $131.7M
Reported positions: 34
Top holdings a year, 3 yrs: +13.6%
Assets under management: $233.9M

Sivik Global Healthcare LLC is a hedge fund that reported 34 positions worth $131.7M in its Q2 2026 13F, filed 2026-07-20. Its largest holdings were Spdr Series Trust (XBI, 14.6%), Cardinal Health Inc (CAH, 3.9%), Call- Bsx 100 @ 75 Exp 04/17/2026 (3.8%). A portfolio copying its top holdings returned 13.6% a year over the last 3 years, against 20.4% for the S&P 500.

Sivik Global Healthcare LLC holdings all 34 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Sivik Global Healthcare LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
XBISpdr Series Trust	14.6%	14.6%	150,000	+0.0%	$19.2M
CAHCardinal Health Inc	3.9%	3.9%	24,000	+0.0%	$5.1M
99DRG5HW3Call- Bsx 100 @ 75 Exp 04/17/2026	3.8%	3.8%	800	+0.0%	$5.0M
JNJJohnson & Johnson	3.7%	3.7%	20,000	+0.0%	$4.9M
MRKMerck & Co. Inc	3.7%	3.7%	40,000	+0.0%	$4.8M
CORCencora Inc Com	3.6%	3.6%	15,000	+0.0%	$4.7M
LLYLilly Eli & Co	3.5%	3.5%	5,000	+0.0%	$4.6M
WATWaters Corp.	3.4%	3.4%	15,000	+0.0%	$4.5M
VRTXVertex Pharmaceuticals Inc	3.4%	3.4%	10,000	+0.0%	$4.5M
ISRGIntuitive Surgical Inc	3.2%	3.2%	9,000	+0.0%	$4.1M
AZNAstrazeneca PLC Ord	3.0%	3.0%	20,000	+0.0%	$3.9M
TMOThermo Fisher Scientific Inc	3.0%	3.0%	8,000	+0.0%	$3.9M
BSXBoston Scientific Corp	3.0%	3.0%	62,000	+0.0%	$3.9M
DHRDanaher Corporation	2.9%	2.9%	20,000	+0.0%	$3.8M
THCTenet Healthcare Corp	2.9%	2.9%	20,000	+0.0%	$3.8M
GILDGilead Sciences	2.6%	2.6%	25,000	+0.0%	$3.5M
HUMHumana Inc	2.6%	2.6%	20,000	+0.0%	$3.5M
MTDMettler-Toledo International I	2.6%	2.6%	2,750	+0.0%	$3.5M
MCKMckesson Corp Com	2.6%	2.6%	4,000	+0.0%	$3.5M
AAgilent Technologies Inc	2.6%	2.6%	30,000	+0.0%	$3.4M
SYKStryker Corporation	2.5%	2.5%	10,000	+0.0%	$3.3M
ABBVAbbvie Inc	2.5%	2.5%	15,000	+0.0%	$3.3M
UHSUniversal Hlth Svcs Inc	2.4%	2.4%	17,500	+0.0%	$3.1M
REGNRegeneron Pharmaceuticals	2.3%	2.3%	4,000	+0.0%	$3.1M
BIOBio-Rad Laboratories, Inc. Class A	2.1%	2.1%	10,000	+0.0%	$2.8M
BIIBBiogen Inc	2.1%	2.1%	15,000	+0.0%	$2.8M
UNHUnitedhealth Group Inc Com	2.1%	2.1%	10,000	+0.0%	$2.7M
GMEDGlobus Med Inc	2.0%	2.0%	30,000	+0.0%	$2.6M
ABTAbbott Laboratories	1.9%	1.9%	25,000	+0.0%	$2.6M
EWEdwards Lifesciences Corp	1.2%	1.2%	20,000	+0.0%	$1.6M
SNNSmith & Nephew PLC	1.2%	1.2%	50,000	+0.0%	$1.6M
ELVElevance Health Inc Formerly	1.1%	1.1%	5,000	+0.0%	$1.5M
EHCEncompass Health Corp	1.1%	1.1%	15,000	+0.0%	$1.5M
CVSCvs Caremark Corporation	1.1%	1.1%	20,000	+0.0%	$1.4M

What Sivik Global Healthcare LLC bought and sold in Q2 2026, against Q1 2026.

New positions

No new positions among the largest holdings.

Added to

No position grew by more than 5%.

Reduced

No position shrank by more than 5%.

Sold out

Nothing sold out.

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year: +21.4% /yr; S&P 500 +20.1%
3 years: +13.6% /yr; S&P 500 +20.4%
5 years: +8.8% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$131.7M	34
Q1 2026	$131.7M	34
Q4 2025	$204.8M	41
Q3 2025	$190.5M	35
Q2 2025	$223.6M	38
Q1 2025	$182.9M	29
Q4 2024	$180.8M	36
Q3 2024	$234.6M	33
Q2 2024	$223.9M	37
Q1 2024	$275.1M	46
Q4 2023	$239.4M	39
Q3 2023	$197.9M	33

Questions about Sivik Global Healthcare LLC's portfolio

What stocks does Sivik Global Healthcare LLC own?

Sivik Global Healthcare LLC's latest 13F, for Q2 2026 and filed Jul 20, 2026, lists 34 positions worth $131.7M. The largest are Spdr Series Trust (XBI) at 14.6%, Cardinal Health Inc (CAH) at 3.9%, Call- Bsx 100 @ 75 Exp 04/17/2026 at 3.8%, Johnson & Johnson (JNJ) at 3.7% and Merck & Co. Inc (MRK) at 3.7%.

What did Sivik Global Healthcare LLC buy last quarter?

Sivik Global Healthcare LLC opened no new positions and grew none by more than 5% among its largest holdings in Q2 2026.

What did Sivik Global Healthcare LLC sell last quarter?

Sivik Global Healthcare LLC sold out of nothing and cut no large position by more than 5% in Q2 2026.

How has Sivik Global Healthcare LLC's portfolio performed?

A portfolio copying Sivik Global Healthcare LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +13.6% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +21.4% against +20.1%. Over 5 years: +8.8% a year against +11.6%.

When is Sivik Global Healthcare LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Sivik Global Healthcare LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Sivik Global Healthcare LLC manage?

Sivik Global Healthcare LLC reported $233.9M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $131.7M.